Home » Topics » BioWorld Asia

BioWorld Asia
RSS

Cyclacel Licenses Rights To Drug Delivery Agent

July 15, 1998

Irish EPA, Monsanto In Dock Over Genetically Altered Beets

July 15, 1998

German Start-Up Mologen To Develop DNA Vaccines

July 15, 1998

New Test Speeds Diagnosis Of Fetal Chromosome Problems

July 15, 1998

Trinity Biotech Takes Over Diatech's Microzyme Products

July 15, 1998

ExonHit Gets FFr5M To Support Gene Expression Technology

July 15, 1998

StressGen Sets Up Network For Cell Protection Studies

July 15, 1998

Stanford Rook Progressing To Phase III With Cancer Therapy

July 15, 1998

Other News To Note

July 15, 1998

EU Mulls Consistency Rules For Biotechnology Drugs

July 15, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 13, 2026.
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
Neurovalens granted FDA approval for PTSD therapy for US veterans
BioWorld
Veterans in the U.S. suffering from post-traumatic stress disorder (PTSD) now have access to Neurovalens Ltd.’s Modius Spero, a wearable neuromodulation device,...
NRF2 activators reported in Vailima Peninsula patent
BioWorld Science
Vailima Peninsula Pty Ltd. has discovered new nuclear factor erythroid 2-related factor 2 (NFE2L2; NRF2) activators potentially useful for the treatment of...